Wutah dodolan YoY sajrone rolas wulan kepungkur: Aardvark Pharma (AARD)

Logo grafis Aardvark Pharma (AARD)

Aardvark Therapeutics Inc (AARD) is based on a rigorous scientific approach to obesity therapy, earning the trust of physicians. The last twelve months (LTM) revenue growth rate demonstrates volatility, with the parameter value equal to 0.00. The brand's future relies on small molecule test results and financial stability. Meanwhile, the environmental footprint remains minimal due to the absence of large-scale production facilities.

Wutah dodolan YoY sajrone rolas wulan kepungkur: Aardvark Therapeutics Corp (AARD) kanggo 23.11.2025 - 19.11.2026

aardvarktherapeutics.com (AARD) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:
- indikator kapitalisasi bursa perusahaan:
Ringkesan analitik perusahaan:AARD (Aardvark Pharma)
Produk seri Aardvark Therapeutics Inc

This indicator measures the rate of change in commercial flow by comparing revenue over the last twelve months on a daily basis to filter out short-term volatility. For Aardvark Therapeutics Inc (AARD), which currently has no products on the market, the TTM annual revenue trend remains zero; however, the future launch of AI-driven obesity drugs will trigger a sharp spike in this metric due to the high margins of the market.

Pesaing Aardvark Therapeutics Inc (AARD)

Ascendis (ASND) - Wutah pendapatan taun lumaku|MDGL - Wutah dodolan YoY sajrone rolas wulan kepungkur|CORT: Wutah dodolan YoY sajrone rolas wulan kepungkur|RYTM: Wutah dodolan YoY (TTM)|AKRO - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Metsera Therapeutics|MoonLake Corp (MLTX) - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur crinetics.com (CRNX)|Wutah pendapatan YoY sajrone 12 wulan kepungkur newamsterdampharma.com NAMS|Wutah dodolan YoY sajrone rolas wulan kepungkur Soleno Therapeutics Inc SLNO|Wutah dodolan YoY (TTM) Amicus Therapeutics Inc FOLD|89bio Corp - Wutah dodolan YoY (TTM)|Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur MiMedx Group, Inc.|Wutah dodolan YoY sajrone rolas wulan kepungkur Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY (TTM) MBX|Wutah pendapatan YoY sajrone 12 wulan kepungkur Altimmune, Inc. ALT|Wutah dodolan YoY (TTM) SGMT (Sagimet Biosciences, Inc.)|BioAge (BIOA) - Wutah pendapatan taun lumaku|BMEA: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Dinamika pendapatan YoY sajrone rolas wulan kepungkur QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|vTv Therapeutics, Inc. - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Agape ATP Corp.|Wutah pendapatan YoY sajrone 12 wulan kepungkur Pluri (PLUR)|Wutah dodolan YoY (TTM) SYBX|Wutah pendapatan taunan sajrone rolas wulan kepungkur Lipocine Inc|Wutah dodolan YoY sajrone rolas wulan kepungkur Matinas BioPharma Holdings MTNB|Wutah pendapatan taunan sajrone rolas wulan kepungkur Spruce Biosciences (SPRB)|GLTO: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan taun lumaku CTCX|LUMO (Lumos Pharma) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan YoY sajrone 12 wulan kepungkur ONVO|RDUS (Radius Pharmaceuticals) - Wutah dodolan YoY (TTM)